463 related articles for article (PubMed ID: 28326813)
1. Breakthrough candidemia in children: clinical and microbiological characteristics, therapeutic strategies and impact on outcomes.
Lai MY; Hsu JF; Chu SM; Wu IH; Huang HR; Lin CC; Lee IT; Chiang MC; Fu RH; Tsai MH
Future Microbiol; 2017 Jun; 12():695-705. PubMed ID: 28326813
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Wang H; Xu YC; Hsueh PR
Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
4. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
5. Candida norvegensis fungemia in a liver transplant recipient.
Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.
Hsu JF; Lai MY; Lee CW; Chu SM; Wu IH; Huang HR; Lee IT; Chiang MC; Fu RH; Tsai MH
BMC Infect Dis; 2018 Apr; 18(1):194. PubMed ID: 29699503
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
Tiraboschi IN; Pozzi NC; Farías L; García S; Fernández NB
Rev Chilena Infectol; 2017 Oct; 34(5):431-440. PubMed ID: 29488584
[TBL] [Abstract][Full Text] [Related]
11. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
12. Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia.
Al Thaqafi AH; Farahat FM; Al Harbi MI; Al Amri AF; Perfect JR
Int J Infect Dis; 2014 Apr; 21():5-9. PubMed ID: 24468816
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of candidemia at a Children's hospital, 2002 to 2006.
Neu N; Malik M; Lunding A; Whittier S; Alba L; Kubin C; Saiman L
Pediatr Infect Dis J; 2009 Sep; 28(9):806-9. PubMed ID: 19636286
[TBL] [Abstract][Full Text] [Related]
14. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
Guinea J; Peláez T; Rodríguez-Créixems M; Torres-Narbona M; Muñoz P; Alcalá L; Bouza E
Med Mycol; 2009; 47(5):515-20. PubMed ID: 18972315
[TBL] [Abstract][Full Text] [Related]
15. Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?
Leenders NH; Oosterheert JJ; Ekkelenkamp MB; De Lange DW; Hoepelman AI; Peters EJ
Int J Infect Dis; 2011 Jul; 15(7):e453-8. PubMed ID: 21530350
[TBL] [Abstract][Full Text] [Related]
16. Austrian clinical practice with anidulafungin in 2008: a multicenter survey.
Perkhofer S; Hell M; Gustorff B; Von Goedecke A; Illievich U; Kratzer C; Moosbauer W; Wimmer P; Zerlauth U; Nachbaur K; Vogel W; Bellmann R; Schwameis F; Lass-Flörl C
J Chemother; 2011 Oct; 23(5):285-9. PubMed ID: 22005061
[TBL] [Abstract][Full Text] [Related]
17. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
18. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
[TBL] [Abstract][Full Text] [Related]
20. Candidaemia in Central Slovenia: A 12-year retrospective survey.
Matos T; Lejko Zupanc T; Skofljanec A; Jazbec A; Matos E; Maver Vodičar P; Germ J; Ciglar T; Tomazin R; Kofol R; Mueller Premru M; Pirs M
Mycoses; 2021 Jul; 64(7):753-762. PubMed ID: 33786895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]